We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+1.92%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$1.95B
AUM Growth
+$76.2M
Cap. Flow
+$63.5M
Cap. Flow %
3.26%
Top 10 Hldgs %
17.61%
Holding
910
New
70
Increased
404
Reduced
353
Closed
72
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEE icon
426
NextEra Energy
NEE
$178B
$973K 0.05%
13,746
-11,557
-46% -$820K
NICE icon
427
Nice
NICE
$6.01B
$966K 0.05%
5,618
+1,650
+42% +$339K
SPG icon
428
Simon Property Group
SPG
$71.6B
$964K 0.05%
6,348
+1,893
+42% +$279K
CCEP icon
429
Coca-Cola Europacific Partners
CCEP
$46.5B
$962K 0.05%
13,202
+996
+8% +$71.7K
P
430
Everpure Inc
P
$33.5B
$958K 0.05%
+14,917
New +$863K
VLO icon
431
Valero Energy
VLO
$91.5B
$957K 0.05%
6,103
-5,943
-49% -$959K
MANH icon
432
Manhattan Associates
MANH
$11.5B
$955K 0.05%
3,872
+560
+17% +$127K
AROC icon
433
Archrock
AROC
$5.88B
$954K 0.05%
47,180
-531
-1% -$10.5K
NSA
434
DELISTED
National Storage Affiliates Trust
NSA
$952K 0.05%
23,096
+8,298
+56% +$313K
ASND icon
435
Ascendis Pharma A/S
ASND
$16.8B
$951K 0.05%
6,975
-59
-0.8% -$8.03K
ETN icon
436
Eaton
ETN
$178B
$947K 0.05%
3,019
+1,569
+108% +$507K
CCOI icon
437
Cogent Communications
CCOI
$512M
$945K 0.05%
16,743
+614
+4% +$36.6K
OLMA icon
438
Olema Pharmaceuticals
OLMA
$938M
$945K 0.05%
+87,312
New +$947K
ANNX icon
439
Annexon
ANNX
$860M
$944K 0.05%
+192,612
New +$996K
ROCK icon
440
Gibraltar Industries
ROCK
$1.48B
$932K 0.05%
13,594
+1,495
+12% +$109K
CCAP icon
441
Crescent Capital BDC
CCAP
$420M
$929K 0.05%
49,482
+31,952
+182% +$571K
NBIX icon
442
Neurocrine Biosciences
NBIX
$16.6B
$929K 0.05%
6,748
-57
-0.8% -$7.82K
LSCC icon
443
Lattice Semiconductor
LSCC
$18.1B
$922K 0.05%
15,900
+11,732
+281% +$810K
APLT
444
DELISTED
Applied Therapeutics
APLT
$920K 0.05%
+197,042
New +$932K
ONTO icon
445
Onto Innovation
ONTO
$15.4B
$920K 0.05%
+4,190
New +$866K
LXRX icon
446
Lexicon Pharmaceuticals
LXRX
$1.06B
$912K 0.05%
+542,899
New +$974K
OII icon
447
Oceaneering
OII
$5.13B
$911K 0.05%
38,505
-112
-0.3% -$2.59K
HUM icon
448
Humana
HUM
$45.6B
$896K 0.05%
2,399
-572
-19% -$193K
NTLA icon
449
Intellia Therapeutics
NTLA
$1.66B
$893K 0.05%
+39,882
New +$950K
MRO
450
DELISTED
Marathon Oil Corporation
MRO
$890K 0.05%
31,055
-3,560
-10% -$98.7K

Similar funds

Hennion & Walsh Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Hennion & Walsh Asset Management held 910 positions worth $1.95B, up 4.1% from $1.87B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Hennion & Walsh Asset Management deployed $63.5M of net new capital in Q2 2024, opening 70 new positions and adding to 404 existing holdings. Its largest new stake was ProShares S&P 500 High Income ETF: 844,883 shares worth $36.8M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was DWS Municipal Income Trust, an estimated $3.23M trimmed.

  • Hennion & Walsh Asset Management's largest Q2 2024 buy was ProShares S&P 500 High Income ETF: 844,883 shares worth $36.8M.
  • Hennion & Walsh Asset Management added most to Goldman Sachs ActiveBeta International Equity ETF in Q2 2024, an estimated $10.5M increase.
  • Hennion & Walsh Asset Management's biggest Q2 2024 reduction was DWS Municipal Income Trust, cutting an estimated $3.23M.
  • Hennion & Walsh Asset Management fully exited JPMorgan Equity Premium Income ETF in Q2 2024, selling an estimated $35.6M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 18% of its $1.95B portfolio in Q2 2024.
  • Hennion & Walsh Asset Management opened 70 new positions and closed 72 in Q2 2024.
  • Hennion & Walsh Asset Management's portfolio value rose 4.1% quarter-over-quarter to $1.95B.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2024, filed 19 Jul 2024.